-
Add to Cart The item has been addedV125454-500gVildagliptin (LAF-237) (C007B-305493)
Price: $472,086.12List Price: $524,540.13Vildagliptin is a dipeptidyl peptidase-4 (CD26) inhibitor. CD26 activates serine proteases in immune/inflammatory cells. Vildagliptin also inhibits dipeptidyl-peptidase 8 (DPRP1) and dipeptidyl-peptidase 9 (DPRP2), which have been correlated to T -
Add to Cart The item has been addedV125454-50mgVildagliptin (LAF-237) (C007B-305494)
Price: $131.37List Price: $145.96Vildagliptin is a dipeptidyl peptidase-4 (CD26) inhibitor. CD26 activates serine proteases in immune/inflammatory cells. Vildagliptin also inhibits dipeptidyl-peptidase 8 (DPRP1) and dipeptidyl-peptidase 9 (DPRP2), which have been correlated to T -
Add to Cart The item has been addedV125454-5gVildagliptin (LAF-237) (C007B-305495)
Price: $7,196.38List Price: $7,995.97Vildagliptin is a dipeptidyl peptidase-4 (CD26) inhibitor. CD26 activates serine proteases in immune/inflammatory cells. Vildagliptin also inhibits dipeptidyl-peptidase 8 (DPRP1) and dipeptidyl-peptidase 9 (DPRP2), which have been correlated to T -
Add to Cart The item has been addedV413963-100mgVLX1570 (C007B-306942)
Price: $2,777.03List Price: $3,085.58InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedV413963-10mgVLX1570 (C007B-306943)
Price: $625.01List Price: $694.46InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedV413963-25mgVLX1570 (C007B-306944)
Price: $1,407.04List Price: $1,563.38InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedV413963-2mgVLX1570 (C007B-306945)
Price: $239.34List Price: $265.93InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedV413963-50mgVLX1570 (C007B-306946)
Price: $1,865.55List Price: $2,072.84InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedV413963-5mgVLX1570 (C007B-306947)
Price: $421.24List Price: $468.04InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedV421591-1mlVLX1570 (C007B-307037)
Price: $279.00List Price: $310.00InformationVLX1570 VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro.TargetsDUB (Cell-free assay) ~10 μMIn vitroVLX1570 is an analogue of b-AP15 that shows higher potency and improved solubility. VLX1570 -
Add to Cart The item has been addedSML1599-5MGVR23 (C005B-311884)
Price: $323.86List Price: $359.84Biochem/physiol Actions Proteasomes are responsible for the cleavage of peptides in an ATP/ubiquitin-dependent manner. VR23 is a potent inhibitor of proteasome that primary targets β:2 of the 20S proteasome catalytic subunit. -
Add to Cart The item has been addedSML1599-25MGVR23 (C005B-311885)
Price: $813.93List Price: $904.37Biochem/physiol Actions Proteasomes are responsible for the cleavage of peptides in an ATP/ubiquitin-dependent manner. VR23 is a potent inhibitor of proteasome that primary targets β:2 of the 20S proteasome catalytic subunit.
